Latest News

Dr Jennifer Huynh of the Olivia Newton-John Cancer Research Institute has won the 2018 Bupa Health Foundation Emerging Health Researcher Award for her research focused on identifying new therapies for colorectal cancer using the immune system.

Melbourne-based Opal BioSciences has joined the US government's Antimicrobial Resistance (AMR) Challenge by committing to work on the development of new anti-infective treatments for life-threatening and hard-to-treat infections.

The agreement will focus on the development of novel oral spray formulations to deliver Zelda’s pharmaceutical-grade cannabis medicines. SUDA is a global leader in oro-mucosal drug delivery.

Cardihab, an Australian-made digital health app designed to improve cardiac rehabilitation participation rates, has announced a $2 million investment led by Australia’s longest running research commercialisation fund, Uniseed.

EpiAxis Therapeutics, a company spun out of the University of Canberra, has expanded its clinical trial program to include two additional recruitment centres for its Phase 1b metastatic breast cancer program.

Researchers at the QIMR Berghofer Medical Research Institute have discovered a simple blood test that could aid the early detection of cancer.

AVITA Medical (ASX:AVH) has announced an institutional placement of $40 million to fund the marketing and sales effort to support US market launch of the RECELL System, clinical and research and development to facilitate pipeline advancement, and general working capital requirements.

Perth medical device company, OncoRes Medical, has progressed to the global finals of an internationally-recognised start-up event. OncoRes, which is developing an imaging tool to improve the...

Labor says it will establish a comprehensive 'root and branch' review of research in Australia if it wins the next federal election.

PharmAust (ASX:PAA), a clinical stage oncology company engaged in a current collaboration with the Olivia Newton-John Cancer Research Institute (ONJCRI), has announced the demonstration of...

Creso Pharma (ASX:CPH) has commenced the process to list on the Toronto Venture Exchange (TSX-V).

Australian medical life sciences company, Medlab Clinical (ASX:MDC), has formally incorporated a wholly owned subsidiary MDC Europe.